Behandeling van patiënten met ernstige glucocorticoïd-refractaire colitis ulcerosa: Ciclosporine of infliximab?

Mark Löwenberg; Nanne K.H. De Boer; Pieter Dewint; Frank Hoentjen

Behandeling van patiënten met ernstige glucocorticoïd-refractaire colitis ulcerosa: Ciclosporine of infliximab?

Translated title of the contribution: Treatment of patients with severe glucocorticoid-refractory ulcerative colitis: Cyclosporine or infliximab?

Mark Löwenberg, Nanne K.H. De Boer, Pieter Dewint, Frank Hoentjen^*

^*Corresponding author for this work

Gastroenterology and hepatology

Research output: Contribution to journal › Article › Professional

Abstract

• Cyclosporine and infliximab are so-called 'rescue-therapies' as last resort for the treatment of patients with severe glucocorticoid-refractory ulcerative colitis. • A recent study found that cyclosporine and infliximab are similar in terms of efficacy in the treatment of patients with severe ulcerative colitis. • Cyclosporine may be prescribed as a bridge to treatment with thiopurines; infliximab may be prescribed when a patient is intolerant or refractory to thiopurines. • Preoperative treatment with cyclosporine or infliximab does not affect the number of postoperative complications.

Translated title of the contribution	Treatment of patients with severe glucocorticoid-refractory ulcerative colitis: Cyclosporine or infliximab?
Original language	Dutch
Article number	A6130
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	157
Issue number	45
Publication status	Published - 1 Dec 2013

Cite this

@article{44ca15fd6c6542ceb0882ee3f8a5e936,

title = "Behandeling van pati{\"e}nten met ernstige glucocortico{\"i}d-refractaire colitis ulcerosa: Ciclosporine of infliximab?",

abstract = "• Cyclosporine and infliximab are so-called 'rescue-therapies' as last resort for the treatment of patients with severe glucocorticoid-refractory ulcerative colitis. • A recent study found that cyclosporine and infliximab are similar in terms of efficacy in the treatment of patients with severe ulcerative colitis. • Cyclosporine may be prescribed as a bridge to treatment with thiopurines; infliximab may be prescribed when a patient is intolerant or refractory to thiopurines. • Preoperative treatment with cyclosporine or infliximab does not affect the number of postoperative complications.",

author = "Mark L{\"o}wenberg and {De Boer}, {Nanne K.H.} and Pieter Dewint and Frank Hoentjen",

year = "2013",

month = dec,

day = "1",

language = "Dutch",

volume = "157",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Bohn Stafleu van Loghum",

number = "45",

}

TY - JOUR

T1 - Behandeling van patiënten met ernstige glucocorticoïd-refractaire colitis ulcerosa

T2 - Ciclosporine of infliximab?

AU - Löwenberg, Mark

AU - De Boer, Nanne K.H.

AU - Dewint, Pieter

AU - Hoentjen, Frank

PY - 2013/12/1

Y1 - 2013/12/1

N2 - • Cyclosporine and infliximab are so-called 'rescue-therapies' as last resort for the treatment of patients with severe glucocorticoid-refractory ulcerative colitis. • A recent study found that cyclosporine and infliximab are similar in terms of efficacy in the treatment of patients with severe ulcerative colitis. • Cyclosporine may be prescribed as a bridge to treatment with thiopurines; infliximab may be prescribed when a patient is intolerant or refractory to thiopurines. • Preoperative treatment with cyclosporine or infliximab does not affect the number of postoperative complications.

AB - • Cyclosporine and infliximab are so-called 'rescue-therapies' as last resort for the treatment of patients with severe glucocorticoid-refractory ulcerative colitis. • A recent study found that cyclosporine and infliximab are similar in terms of efficacy in the treatment of patients with severe ulcerative colitis. • Cyclosporine may be prescribed as a bridge to treatment with thiopurines; infliximab may be prescribed when a patient is intolerant or refractory to thiopurines. • Preoperative treatment with cyclosporine or infliximab does not affect the number of postoperative complications.

UR - http://www.scopus.com/inward/record.url?scp=84891330361&partnerID=8YFLogxK

M3 - Article

C2 - 24050446

AN - SCOPUS:84891330361

SN - 0028-2162

VL - 157

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

IS - 45

M1 - A6130

ER -

Behandeling van patiënten met ernstige glucocorticoïd-refractaire colitis ulcerosa: Ciclosporine of infliximab?

Abstract

Other files and links

Cite this